BioMarkerIQ is building the next generation of AI-driven cancer diagnostics. Our platform uses machine learning to identify predictive biomarker patterns associated with early-stage cancer, enabling earlier detection, more personalized care, and better survival outcomes. By turning complex biological data into actionable clinical insights, BioMarkerIQ aims to redefine cancer screening and accelerate the shift toward preventive, precision healthcare.